Literature DB >> 28285310

Incidence and Causes of Intentional Fetal or Neonatal Demise in Twin-Twin Transfusion Syndrome.

Marjolijn S Spruijt1, Ellen Tameeris, De-Peng Zhao, Johanna M Middeldorp, Monique C Haak, Dick Oepkes, Enrico Lopriore.   

Abstract

INTRODUCTION: The aim of this study is to evaluate the incidence and causes of intentional fetal and neonatal demise in twin-twin transfusion syndrome (TTTS).
MATERIAL AND METHODS: All TTTS pregnancies managed at our centre between 2000 and 2014 were included. We evaluated incidence and causes of intentional fetal/neonatal demise, defined as termination of pregnancy, selective fetal reduction, or withdrawal of neonatal intensive care.
RESULTS: Intentional fetal/neonatal demise occurred in 9.8% (110/1,122) of fetuses and was due to termination of pregnancy (2.2%), selective fetal reduction (4.2%), or withdrawal of neonatal intensive care (3.4%). Reasons for termination of pregnancy included complications of laser treatment (72.0%), severe fetal anomaly (20.0%), and unwanted pregnancy (8.0%). Reasons for selective fetal reduction were technical difficulties to perform laser surgery (51.1%), fetal complications (38.3%), and parental preference for fetal reduction rather than laser treatment (10.6%). Reasons for withdrawal of neonatal intensive care treatment were severe cerebral injury (47.4%), severe pulmonary complications (15.8%), birth asphyxia (5.3%), multiple complications of TTTS and/or prematurity combined (21.1%), or other (10.5%).
CONCLUSIONS: Intentional fetal or neonatal demise in TTTS occurs frequently and is often due to complications after laser surgery and/or severe (cerebral) injury in affected fetuses or neonates.
© 2017 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Keywords:  Cerebral injury; Fetoscopic laser therapy; Selective fetal reduction; Termination of pregnancy; Twin-twin transfusion syndrome; Withdrawal of neonatal intensive care

Mesh:

Year:  2017        PMID: 28285310      PMCID: PMC5804830          DOI: 10.1159/000461580

Source DB:  PubMed          Journal:  Fetal Diagn Ther        ISSN: 1015-3837            Impact factor:   2.587


  17 in total

Review 1.  Twenty-Five Years of Fetoscopic Laser Coagulation in Twin-Twin Transfusion Syndrome: A Systematic Review.

Authors:  Joost Akkermans; Suzanne H P Peeters; Frans J Klumper; Enrico Lopriore; Johanna M Middeldorp; Dick Oepkes
Journal:  Fetal Diagn Ther       Date:  2015-08-01       Impact factor: 2.587

2.  The outcome of monochorionic diamniotic twin gestations in the era of invasive fetal therapy: a prospective cohort study.

Authors:  Liesbeth Lewi; Jacques Jani; Isaac Blickstein; Agnes Huber; Leonardo Gucciardo; Tim Van Mieghem; Elisa Doné; Anne-Sophie Boes; Kurt Hecher; Eduardo Gratacós; Paul Lewi; Jan Deprest
Journal:  Am J Obstet Gynecol       Date:  2008-06-04       Impact factor: 8.661

3.  [Practice guideline 'Perinatal management of extremely preterm delivery'].

Authors:  Monique W M de Laat; Melanie M Wiegerinck; Frans J Walther; Nicole Boluyt; Ben Willem J Mol; Joris A M van der Post; Jan M M van Lith; Martin Offringa
Journal:  Ned Tijdschr Geneeskd       Date:  2010

Review 4.  Neonatal morbidity in twin-twin transfusion syndrome.

Authors:  Enrico Lopriore; Dick Oepkes; Frans J Walther
Journal:  Early Hum Dev       Date:  2011-07-23       Impact factor: 2.079

5.  Neurodevelopmental outcome at 2 years in twin-twin transfusion syndrome survivors randomized for the Solomon trial.

Authors:  Jeanine M M van Klink; Femke Slaghekke; Marina A Balestriero; Barbara Scelsa; Paola Introvini; Mariangela Rustico; Stefano Faiola; Monique Rijken; Hendrik M Koopman; Johanna M Middeldorp; Dick Oepkes; Enrico Lopriore
Journal:  Am J Obstet Gynecol       Date:  2015-08-20       Impact factor: 8.661

6.  Improvement in neurodevelopmental outcome in survivors of twin-twin transfusion syndrome treated with laser surgery.

Authors:  Jeanine M M van Klink; Hendrik M Koopman; Erik W van Zwet; Johanna M Middeldorp; Frans J Walther; Dick Oepkes; Enrico Lopriore
Journal:  Am J Obstet Gynecol       Date:  2014-01-08       Impact factor: 8.661

7.  Fetoscopic laser coagulation of the vascular equator versus selective coagulation for twin-to-twin transfusion syndrome: an open-label randomised controlled trial.

Authors:  Femke Slaghekke; Enrico Lopriore; Liesbeth Lewi; Johanna M Middeldorp; Erik W van Zwet; Anne-Sophie Weingertner; Frans J Klumper; Philip DeKoninck; Roland Devlieger; Mark D Kilby; Maria Angela Rustico; Jan Deprest; Romain Favre; Dick Oepkes
Journal:  Lancet       Date:  2014-03-07       Impact factor: 79.321

8.  Stage-related outcome in twin-twin transfusion syndrome treated by fetoscopic laser coagulation.

Authors:  Agnes Huber; Werner Diehl; Thomas Bregenzer; Bernd-Joachim Hackelöer; Kurt Hecher
Journal:  Obstet Gynecol       Date:  2006-08       Impact factor: 7.661

9.  Cerebral injury in twin-twin transfusion syndrome treated with fetoscopic laser surgery.

Authors:  Marjolijn Spruijt; Sylke Steggerda; Mirjam Rath; Erik van Zwet; Dick Oepkes; Frans Walther; Enrico Lopriore
Journal:  Obstet Gynecol       Date:  2012-07       Impact factor: 7.661

Review 10.  Cerebral injury and neurodevelopmental impairment after amnioreduction versus laser surgery in twin-twin transfusion syndrome: a systematic review and meta-analysis.

Authors:  Jeanine M M van Klink; Hendrik M Koopman; Erik W van Zwet; Dick Oepkes; Frans J Walther; Enrico Lopriore
Journal:  Fetal Diagn Ther       Date:  2012-08-24       Impact factor: 2.587

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.